Medical Foods for Inborn Errors of Metabolism Market is growing with a CAGR of 13.5% by 2030
Data Bridge Market research has just completed and published a study report with the title “ Medical Foods for Inborn Errors of Metabolism Market ” (including the United States, Europe, China, Japan, India, South East Asia, and other regions). The report emphasizes opportunities, and risks, and leverages this information to help readers make strategic and tactical decisions. The Forklift Truck report encompasses the key developments in the market with respect to the current scenario and the forthcoming advancements. Data Bridge Market Research has recently published a Report, titled, “ Medical Foods for Inborn Errors of Metabolism Market ” The report offers an extensive analysis of key growth strategies, drivers, opportunities, key segment, Porter’s Five Forces analysis, and competitive landscape.
The term Inborn Error of Metabolism (IEM) is used for a large group of genetic diseases. These diseases are exceptionally rare and they have an incidence of 1 in 2500 live births. Many of these diseases can be very severe and life-threatening if not treated properly within time and with the help of specific diets or other enzyme replacement or substitution therapies.
Download PDF Sample Report (Including Graphs, Charts, and List of Figures) @ https://www.databridgemarketresearch.com/request-a-sample/?dbmr=global-medical-foods-for-inborn-errors-of-metabolism-market&Shri
The global medical foods for inborn errors of metabolism market report provides details of market share, new developments, and product pipeline analysis, the impact of domestic and localized market players, analyzes opportunities in terms of emerging revenue pockets, changes in market regulations, product approvals, strategic decisions, product launches, geographic expansions, and technological innovations in the market. To understand the analysis and the market scenario, contact us for an analyst brief. Our team will help you create a revenue-impact solution to achieve your desired goal. The scalability and business expansion of the retail units in the developing countries of various regions and partnership with suppliers for safe distribution of machine and drugs products are the major drivers which propelled the demand of the market in the forecast period.
Data Bridge Market Research analyzes that the market is growing with a CAGR of 13.5% in the forecast period of 2023 to 2030 and is expected to reach USD 6,717.76 million by 2030 from USD 2,477.81 million in 2022.
The Inborn Errors of Metabolism (IEMs) are a group of disorders in which the body fails to convert food into energy. Due to mutations in genes, there is less or no production of specific enzymes, and these enzymes are responsible for breaking down certain substances. This breakdown leads to the accumulation of some toxic substances and results in severe complications. To treat these disorders, the concerned patients are given specific diets, which are also known as medical foods, under the supervision of physicians.
Fundamental Aim of this Market Report
- Factors influencing This Market Size and growth rate.
- Major alterations to this market in the near future.
- Notable Market rivals around the world.
- Future Scope and Product Outlook
- Future-promising emerging markets.
- The Market Presents Difficult Challenges and Threats.
Opportunities
- Government Initiatives and Programs for Creating Awareness About Inborn Errors of Metabolism
Governments around the world have recognized the importance of raising awareness about IEMs and have implemented various initiatives and programs to address this need. These initiatives aim to educate healthcare professionals, individuals and families affected by IEMs, and the general public, which is expected to provide opportunities for market growth.
- Increasing Collaborations and Partnerships in the Market
Growing partnerships and collaborations in the market are changing the landscape, driving innovation, advancing R&D, and improving patient care. These collaborations bring together key stakeholders such as pharmaceutical companies, medical food manufacturers, research institutes, and patient advocacy groups. By combining their expertise, resources, and networks, these partnerships will accelerate the R&D of improved treatments and medicines for people with IEMs. In addition, the strategic initiatives taken by key market players are expected to provide structural integrity and future opportunities for market growth in the forecast period of 2023-2030.
Some of the major market players operating in the global medical foods for inborn errors of metabolism market are Nestlé Health Science (A subsidiary of Nestle), Nutricia (A subsidiary of Danone), Baxter, Meiji Holdings Co., Ltd., Piam Farmaceutici S.P.A., Solace Nutrition, Abbott, Mead Johnson & Company, LLC. (A Subsidiary of Reckitt Benckiser Group plc.), Ajinomoto Cambrooke, Inc. (A Subsidiary of Ajinomoto Co., Inc.), Galen Limited, PKU-MDmil, Pristine Organics Private Limited, APR, Fresenius Kabi AG (Subsidiary of Fresenius SE & Co. KGaA), PKU Perspectives, EBM Medical, Orpharma Pty Ltd., B. Braun SE, Primus Pharmaceuticals, Inc., Kate Farms, Hexagonnutrition Ltd., Ener-G Foods, Inc., Promin Metabolics, and Dr. Schär AG / SPA) among others.
To Gain More Insights into the Market Analysis, Browse the Summary of the Research Report@ https://www.databridgemarketresearch.com/reports/global-medical-foods-for-inborn-errors-of-metabolism-market?Shri
Recent Developments
- In October 2022, Galen Limited introduced the first solid-dose protein substitution option for Tyrosinemia, called TYR EASY Tablets in the U.K. market. Tyrosinemia (TYR) patients over the age of 8 can now choose from a wider variety of protein substitutes that best suit their daily needs.
- In July 2020, Baxter, a global leader in clinical nutrition, and VIPUN Medical, a company that develops technological solutions to improve medical nutrition, announced an agreement to commercialize VIPUN’s gastric monitoring system. As part of the agreement, Baxter will support clinical trials necessary to obtain regulatory approval in key markets worldwide and global distribution rights.
Medical Foods for Inborn Errors of Metabolism Market Scope
Products
- Amino Acids
- Glytactin With Gmp Amino Acid-Modified Infant Formula With Iron
- Low-Calcium/Vitamin D-Free Infant Formula With Iron
- Low Protein Food
- Others
On the basis of products, the market is segmented into amino acid, glytactin with GMP amino acid-modified infant formula with iron, low-calcium/vitamin D-free infant formula with iron, low protein food, and others.
Diseases
- Phenylketonuria (PKU)
- Maple Syrup Urine Disease (MSUD)
- Homocystinuria
- Methylmalonic Acidemia
- Organic Acidurias
- Propionic Acidemia
- Isovaleric Acidemia
- Disorders of Leucine Metabolism
- Glutaric Acidemia Type I
- Renal Disease
- Tyrosinemia Types I and II
- Urea Cycle Disorders
- Others
On the basis of diseases, the market is segmented into phenylketonuria (PKU), tyrosinemia types I And II, maple syrup urine disease (MSUD), homocystinuria, glutaric acidemia type I, urea cycle disorders, methylmalonic acidemia, isovaleric acidemia, organic acidurias, renal disease, propionic academia, disorders of leucine metabolism, and others.
Age Group
- Infants
- Weaning
- Adolescent
- Adults
On the basis of age group, the market is segmented into infants, weaning, adolescent, and adults.
Forms
- Powder
- Liquid
- Tablets
- Gels
- Others
On the basis of forms, the market is segmented into powder, liquid, tablets, gels, and others.
Packaging
- Can
- Jar
- Packets
- Bottle
- Others
On the basis of packaging, the market is segmented into can, jar, packets, bottle, and others.
Distribution Channel
- Retail Pharmacy
- Hospital Pharmacy
- Online Pharmacy
- Drugs Stores
- Others
On the basis of distribution channel, the market is segmented into retail pharmacy, hospital pharmacy, online pharmacy, drugs store, and others.
Key highlights of this Market report:
- Growth rate
- Remuneration prediction
- Consumption graph
- Market concentration ratio
- Secondary industry competitors
- Competitive structure
- Major restraints
- Market drivers
- Regional bifurcation
- Competitive hierarchy
- Current market tendencies
- Market concentration analysis
What benefits does the DBMR study is going to provide?
- Latest industry influencing trends and development scenario
- Open up New Markets
- To Seize powerful market opportunities
- Key decision in planning and to further expand market share
- Identify Key Business Segments, Market proposition & Gap Analysis
- Assisting in allocating marketing investments
Table of Contents:
-
1 INTRODUCTION
1.1 OBJECTIVES OF THE STUDY
1.2 MARKET DEFINITION
1.3 OVERVIEW
1.4 CURRENCY AND PRICING
1.5 LIMITATIONS
1.6 MARKETS COVERED
2 MARKET SEGMENTATION
2.1 MARKETS COVERED
2.2 GEOGRAPHICAL SCOPE
2.3 YEARS CONSIDERED FOR THE STUDY
2.4 DBMR TRIPOD DATA VALIDATION MODEL
2.5 PRIMARY INTERVIEWS WITH KEY OPINION LEADERS
2.6 MULTIVARIATE MODELLING
2.7 PRODUCTS LIFELINE CURVE
2.8 DBMR MARKET POSITION GRID
2.9 SECONDARY SOURCES
2.1 ASSUMPTIONS
3 EXECUTIVE SUMMARY
4 PREMIUM INSIGHT
4.1 PESTEL ANALYSIS
4.2 PORTER’S FIVE FORCES MODEL
4.3 GLOBAL MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET ANALYSIS
4.4 PATENT ANALYSIS
5 PIPELINE ANALYSIS
6 EPIDEMIOLOGY
7 INDUSTRY INSIGHTS
Continued…
Browse Detailed Summary of Research Report with TOC: https://www.databridgemarketresearch.com/toc/?dbmr=global-medical-foods-for-inborn-errors-of-metabolism-market&Shri
Key Benefits of the Report:
- This study presents the analytical depiction of this industry along with the current trends and future estimations to determine the imminent investment pockets.
- The report presents information related to key drivers, restraints, and opportunities along with a detailed analysis of this market share.
- The current market is quantitatively analyzed to highlight the market growth scenario.
- Porter’s five forces analysis illustrates the potency of buyers & suppliers in the market.
- The report provides a detailed this industry analysis based on competitive intensity and how the competition will take shape in the coming years.
Top DBMR Healthcare Reports:
https://www.databridgemarketresearch.com/reports/global-cardasil-treatment-market?Shri
https://www.databridgemarketresearch.com/reports/global-aestheticcosmetic-lasers-market?Shri
https://www.databridgemarketresearch.com/reports/global-yeast-infection-market?Shri
About Data Bridge Market Research:
An absolute way to forecast what future holds is to comprehend the trend today!
Data Bridge Market Research set forth itself as an unconventional and neoteric Market research and consulting firm with unparalleled level of resilience and integrated approaches. We are determined to unearth the best market opportunities and foster efficient information for your business to thrive in the market. Data Bridge endeavours to provide appropriate solutions to the complex business challenges and initiates an effortless decision-making process. Data Bridge is an aftermath of sheer wisdom and experience which was formulated and framed in the year 2015 in Pune.
Data Bridge Market Research has over 500 analysts working in different industries. We have catered more than 40% of the fortune 500 companies globally and have a network of more than 5000+ clientele around the globe. Data Bridge adepts in creating satisfied clients who reckon upon our services and rely on our hard work with certitude. We are content with our glorious 99.9 % client satisfying rate.
Contact Us:-
Data Bridge Market Research
US: +1 888 387 2818
UK: +44 208 089 1725
Hong Kong: +852 8192 7475
Email:- corporatesales@databridgemarketresearch.com
